About Precede
Precede is a company based in Boston (United States) founded in 2021 by Rehan Verjee.. Precede has raised $57 million across 1 funding round from investors including Stealth. Precede offers products and services including Liquid Biopsy Platform. Precede operates in a competitive market with competitors including Guardant Health, GRAIL, Personalis, Thrive Earlier Detection and Delfi Diagnostics, among others.
- Headquarter Boston, United States
- Founders Rehan Verjee
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$57 M (USD)
in 1 rounds
-
Latest Funding Round
$57 M (USD), Series C
Oct 10, 2023
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Precede
Precede offers a comprehensive portfolio of products and services, including Liquid Biopsy Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Profiles circulating chromatin from blood for gene activation analysis.
Unlock access to complete
Funding Insights of Precede
Precede has successfully raised a total of $57M through 1 strategic funding round. The most recent funding activity was a Series C round of $57 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series C — $57.0M
-
First Round
First Round
(10 Oct 2023)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2023 | Amount | Series C - Precede | Valuation | Stealth |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Precede
Precede has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Stealth. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Ruggedized industrial computers and peripherals are supplied for various sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Precede
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Precede
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Precede Comparisons
Competitors of Precede
Precede operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, GRAIL, Personalis, Thrive Earlier Detection and Delfi Diagnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Circulating tumor DNA is screened for early cancer detection.
|
|
| domain | founded_year | HQ Location |
Genomic sequencing and diagnosis software is provided for healthcare.
|
|
| domain | founded_year | HQ Location |
Blood-based liquid biopsy tests for multiple cancer detection are provided.
|
|
| domain | founded_year | HQ Location |
Provider of DNA sequencing for cancer detection
|
|
| domain | founded_year | HQ Location |
Provider of cell-free cancer liquid biopsy test
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Precede
Frequently Asked Questions about Precede
When was Precede founded?
Precede was founded in 2021 and raised its 1st funding round 2 years after it was founded.
Where is Precede located?
Precede is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Who is the current CEO of Precede?
Rehan Verjee is the current CEO of Precede. They have also founded this company.
Is Precede a funded company?
Precede is a funded company, having raised a total of $57M across 1 funding round to date. The company's 1st funding round was a Series C of $57M, raised on Oct 10, 2023.
What does Precede do?
Precede was established in 2021 in Boston, United States, within the biotechnology sector focused on oncology. A genome-wide liquid-biopsy platform is utilized to analyze circulating chromatin and the DNA methylome. This approach supports cancer diagnosis and aids in the creation of precision medicines. Operations emphasize diagnostic services for early detection and therapeutic development in the healthcare field.
Who are the top competitors of Precede?
Precede's top competitors include Guardant Health, GRAIL and Personalis.
What products or services does Precede offer?
Precede offers Liquid Biopsy Platform.
Who are Precede's investors?
Precede has 1 investor. Key investors include Stealth.